Please enable Javascript to use all features and improve your user experience.
ST Herbst 2022 der DGNC
Programme
People
Search
DE
Back
Sektion Neuroonkologie
Neuroonkologie
Molekulare Diagnostik und Therapie I
Appointment
Date:
27/10/2022
Time:
14:45
–
15:45
Location / Stream:
Saal A
Vorsitz
Michael Sabel
Düsseldorf
Christian Freyschlag
Innsbruck / AT
Programme
14:45
–
14:55
7 Min.
3 Min.
Abstractvortrag
Establishment of Cell Culture Models from Intracerebral Carcinoma Metastases for Personalized Preclinical Evaluation of Novel Therapeutic Approaches
Sebastian Jeising (Düsseldorf)
14:55
–
15:05
7 Min.
3 Min.
Abstractvortrag
In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma
Sebastian Jeising (Düsseldorf)
15:05
–
15:15
7 Min.
3 Min.
Abstractvortrag
Drug repurposing of tonabersat as a potent gap junction inhibitor sensitizes primary glioblastoma cells for temozolomide
Anna-Laura Potthoff (Bonn)
15:15
–
15:25
7 Min.
3 Min.
Abstractvortrag
Inhibition of intercellular communication via gap junctions renders medulloblastoma cells more susceptible for cytotoxic therapy
Matthias Schneider (Bonn)
15:25
–
15:35
7 Min.
3 Min.
Abstractvortrag
The Alcatraz-Strategy: A novel multimodal therapeutic approach for glioblastoma
Matthias Schneider (Bonn)
15:35
–
15:45
7 Min.
3 Min.
Abstractvortrag
[
68
Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [
177
Lu]Lu-PSMA therapy in relapsing high-grade glioma
Peter Truckenmüller (Berlin)
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy